Výsledky vyhledávání - "C-Peptide (Blood)"

Akademický článek

C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels

Autor: Chifa Ma, Yiwen Liu, Shuli He, Jingbo Zeng, Pingping Li, Chunxiao Ma, Fan Ping, Huabing Zhang, Lingling Xu, Wei Li, Yuxiu Li

Publikováno v: Frontiers in Endocrinology, Vol 11 (2020)

BackgroundThe data on the relationship between normal-ranged serum uric acid (SUA), β-cell function, and non-alcoholic fatty liver disease (NAFLD) are complicated and insufficient. Moreover, uric acid is excreted by kidney, and SUA levels may be aff

Externí odkaz: https://doaj.org/article/927bebe6833a4000942c2b533ce182a3

Zobrazit plný text záznamu

Central venous catheter-associated thrombosis in children with congenital hyperinsulinism

Autor: Amish Chinoy, Raja Padidela, Ross J. Craigie, Maria Salomon-Estebanez, Mark J. Dunne, Philip Murray, John D. Grainger, Indraneel Banerjee, Daphne Yau, Mars Skae

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2019)
Endocrinology, Diabetes & Metabolism Case Reports
Yau, D, Salomon-Estebanez, M, Chinoy, A, Grainger, J, Craigie, R, Padidela, R, Skae, M, Dunne, M, Murray, P & Banerjee, I 2019, ' Central venous catheter-associated thrombosis in children with congenital hyperinsulinism ', Endocrinology, diabetes & metabolism case reports, vol. 2019, no. 1 . https://doi.org/10.1530/EDM-19-0032

Summary Congenital hyperinsulinism (CHI) is an important cause of severe hypoglycaemia in infancy. To correct hypoglycaemia, high concentrations of dextrose are often required through a central venous catheter (CVC) with consequent risk of thrombosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2257963112db68d1c52815bcd7abc8dd
https://edm.bioscientifica.com/view/journals/edm/2019/1/EDM19-0032.xml

Zobrazit plný text záznamu

Insulin autoimmune syndrome

Autor: Evgeny Vasilyev, Marina Yukina, Nurana Nuralieva, Ekaterina Troshina, Maksim Solovyev

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2020)

Summary Insulin autoimmune syndrome (Hirata’s disease) is a disorder caused by development of autoantibodies to insulin and manifested by hypoglycaemic syndrome. The overwhelming majority of physicians do not include it in the differential diagnosi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97029b93c701212255db9f82f13f5942
https://pubmed.ncbi.nlm.nih.gov/32554828

Zobrazit plný text záznamu

Type B insulin resistance syndrome in a patient with type 1 diabetes

Autor: Åke, Sjöholm, Maria João, Pereira, Thomas, Nilsson, Torbjörn, Linde, Petros, Katsogiannos, Jan, Saaf, Jan W, Eriksson

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2020)

Summary Type B insulin resistance syndrome (TBIRS) is a very rare autoimmune disorder with polyclonal autoantibodies against the insulin receptor, resulting in severe and refractory hyperglycemia. Described here is a patient who within a few months a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2d86b9e669bd4094e67d46b412abc72d
http://europepmc.org/articles/PMC7219126

Zobrazit plný text záznamu

Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral

Autor: Yuzo Mizuno, Saya Suzuki, Kazuhisa Kusuki

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2020)

Summary A 72-year-old man with no history of diabetes was referred to our department due to hyperglycemia during pembrolizumab treatment for non-small-cell lung carcinoma. His blood glucose level was 209 mg/dL, but he was not in a state of ketosis or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a236e6645f0bdc6e6b7df79d20ed1c
http://europepmc.org/articles/PMC7219158

Zobrazit plný text záznamu

The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide

Autor: Simeon I. Taylor, Diana Rus, Adam H. Neidert, Rita Hench, Baris Akinci, Rasimcan Meral, Frank DiPaola, Elif A. Oral, Maria Westerhoff

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-9 (2020)
Endocrinology, Diabetes & Metabolism Case Reports

Summary A patient with atypical partial lipodystrophy who had a transient initial response to metreleptin experienced acute worsening of her metabolic state when neutralizing antibodies against metreleptin appeared. Because her metabolic status conti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::057579038ac17c089add829235048d8f
https://doi.org/10.1530/edm-19-0139

Zobrazit plný text záznamu

Non classic presentations of a genetic mutation typically associated with transient neonatal diabetes

Autor: Adrian Scott, Charlotte Elder, Janani Devaraja

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2020)

Summary This case report describes a family pedigree of a mother and her children with an E227K mutation in the KCNJ11 gene. People with this particular gene mutation typically present with transient neonatal diabetes; with more than half the cohort

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fde798dc2ec06aa90762b6eaedbbb86
https://doi.org/10.1530/edm-19-0125

Zobrazit plný text záznamu

Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism

Autor: Jerry R. Greenfield, Shivani K. Patel, Venessa T. Chin

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2019)

Summary Durvalumab is a programmed cell death ligand 1 inhibitor, which is now approved in Australia for use in non-small-cell lung and urothelial cancers. Autoimmune diabetes is a rare immune-related adverse effect associated with the use of immune

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e545cf0f4611fde49e8fe351f93f02
http://europepmc.org/articles/PMC6935712

Zobrazit plný text záznamu

Significant polar vasculosis in a patient with a 30-year history of type 2 diabetes

Autor: Hiroki Mizuno, Kenichi Ohashi, Yoshifumi Ubara, Tatsuya Suwabe, Takeshi Fujii, Naoki Sawa, Masayuki Yamanouchi, Junichi Hoshino, Rikako Hiramatsu, Yasuhiro Oda

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2019)

Summary We report the renal histology of a 66-year-old man with hypertension, cardiovascular disease, and a 30-year history of type 2 diabetes mellitus with proliferative diabetic retinopathy, diabetic neuropathy, and diabetic foot status post toe am

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caefe9a6c67a6a5029ed6561b330513e
http://europepmc.org/articles/PMC6865358

Zobrazit plný text záznamu

Simultaneous onset of type 1 diabetes mellitus and silent thyroiditis under durvalumab treatment

Autor: Laia Casamitjana Espuña, Ismael Capel, Assumpta Caixàs, Jose León Mengíbar, Mercedes Rigla, Isabel Mazarico, Teresa Bonfill

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-4 (2019)

Summary Durvalumab, a human immunoglobulin G1 kappa monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 and CD80 (B7.1) molecules, is increasingly used in advanced neoplasias. Durvalumab use is asso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de75843c233273b2984c8d9afa86ae8
https://doi.org/10.1530/edm-19-0045

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání